Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 47-1643994 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To find solutions for people living with als now and for the future by utilizing knowledge of patients, leading researchers and technology to seek immediate solutions to improve the lives of those living with als until a treatment or cure is found; discover what causes als; develop models to understand als and screen for drug and cellular therapy; discover therapies that could substantially slow or halt the progress of als and ultimately cure the disease; provide all gathered information free for worldwide use by clinicians, scientists and pharma to rapidly advance therapeutics.
Principal Officer
Clare Durrett
Total Revenue
$2.8M
FY2024
Total Expenses
$3.2M
FY2024
Net Assets
$6.9M
Program Ratio
96.8%
expenses on programs
Employees
1
Volunteers
20
Board Members
9
Voting
9
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.